Microban International, a global leader in built-in antimicrobial product protection, announced today a new initiative designed to help medical device manufacturers get to market quicker with antimicrobial solutions for 510(k) registered medical devices used in hospitals and other healthcare facilities.
Helthcare-acquired infections (HAIs) are responsible for approximately 100,000 deaths per year and incur in excess of $20 billion in healthcare costs. "Our expertise utilizing a breadth of antimicrobial technologies enables us to help manufacturers of medical devices develop safer and more effective antimicrobial solutions for their products and provides an important resource to help address the growing concern over hospital acquired infections," said David Meyers, president and CEO of Microban International.
Microban has an extensive portfolio of organic, inorganic and organometallic antimicrobial technologies which enable it to choose the optimal technology for the device. It works closely with customers to engineer antimicrobial solutions that are designed to meet the specific needs of each unique device application, evaluating important criteria such as: antimicrobial performance utilizing industry standard protocols and testing for specific microorganisms and relevant kill times; durability requirements and exposure time periods; product usage environment; manufacturing parameters; and necessary regulatory approvals.
With more than 20 years of experience engineering antimicrobial solutions across a breadth of product applications and materials including expertise with thermoplastics, cross-linked thermosets, coatings and textiles Microban says it can help medical device manufacturers to more effectively and accurately screen and optimize potential antimicrobial technologies. In addition, its onsite state-of-the-art microbiology laboratory utilizes a high throughput quantitative testing system that enables Microban to quickly and reliably deliver accurate data and proof of concept studies.
Microban offers full service support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance. For more information, medical manufacturers should visit http://www.microban.com/microban-medical.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.